Oncolytics Biotech Inc T.ONC

Alternate Symbol(s): ONCY

Healthcare Biotechnology

Oncolytics Biotech Inc. is a clinical-stage biotechnology company. The Company is focused on developing pelareorep, an intravenously delivered immunotherapeutic agent that activates the innate and adaptive immune systems and weakens tumor defense mechanisms. This compound induces anti-cancer immune responses and promotes an inflamed tumor phenotype turning cold tumors hot through innate and adaptive immune responses to treat a variety of cancers. This improves the ability of the immune system to fight cancer, making tumors more susceptible to a broad range of oncology treatments. The Company’s primary focus is to advance its programs in hormone receptor-positive / human epidermal growth factor 2- negative (HR+/HER2-) metastatic breast cancer and advanced/metastatic pancreatic ductal adenocarcinoma to registration-enabling clinical studies. In addition, it is exploring opportunities for registrational programs in other gastrointestinal cancers through its GOBLET platform study.

TSX:ONC - Post by User

Oncolytics Biotech Inc > pssssst

Bullboard Posts

Next >>

Comment by canadafanon Nov 23, 2020 4:49pm

340 Views

Post# 31954906

RE:pssssst

The board is not silent exactly
but not that big of a deal.
for those who have been around, know full well Onc share price has a long way to go.
well above $10 ps
nice movement today, for sure.
once the price is above $5 on the USA side ( $6.60 ++ CDN) the price will actually move in larger increments.
RBC has a $9 target & that is pre- conference news ( coming this Dec 9th or so,).
the recent giobkastoma results have shown efficacy & that alone merits a $$5 usd ps stock.
Enjoy

Bullboard Posts

Next >>

Mastering options Greeks: Essential knowledge for informed trading